United States · FDA National Drug Code directory

Ondansetron Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-1357_d48ed97a-a53e-4757-9712-cc4bf0acd961
Product NDC
71335-1357
Form
TABLET, FILM COATED
Composition / generic term
Ondansetron Hydrochloride
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20070731
Source listing expiry
20261231

Source-listed ingredients

  • ONDANSETRON HYDROCHLORIDE — 8 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 5 TABLET, FILM COATED in 1 BOTTLE (71335-1357-0) · 71335-1357-0
  • 10 TABLET, FILM COATED in 1 BOTTLE (71335-1357-1) · 71335-1357-1
  • 15 TABLET, FILM COATED in 1 BOTTLE (71335-1357-2) · 71335-1357-2
  • 4 TABLET, FILM COATED in 1 BOTTLE (71335-1357-3) · 71335-1357-3
  • 3 TABLET, FILM COATED in 1 BOTTLE (71335-1357-4) · 71335-1357-4
  • 12 TABLET, FILM COATED in 1 BOTTLE (71335-1357-5) · 71335-1357-5
  • 20 TABLET, FILM COATED in 1 BOTTLE (71335-1357-6) · 71335-1357-6
  • 30 TABLET, FILM COATED in 1 BOTTLE (71335-1357-7) · 71335-1357-7
  • 60 TABLET, FILM COATED in 1 BOTTLE (71335-1357-8) · 71335-1357-8
  • 6 TABLET, FILM COATED in 1 BOTTLE (71335-1357-9) · 71335-1357-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →